Goldman Sachs Maintains Buy on Legence, Raises Price Target to $63
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $52 to $63.
Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $52 to $63.